Molecular subtype specific efficacy of MEK inhibitors in pancreatic cancers.
Brauswetter D, Gurbi B, Varga A, Várkondi E, Schwab R, Bánhegyi G, Fábián O, Kéri G, Vályi-Nagy I, Peták I.
Brauswetter D, et al. Among authors: varga a.
PLoS One. 2017 Sep 28;12(9):e0185687. doi: 10.1371/journal.pone.0185687. eCollection 2017.
PLoS One. 2017.
PMID: 28957417
Free PMC article.